CraniSeal Dural Sealant
FDA premarket approval P220014/S002 · decided 2023-12-20
Approval details
- PMA number
- P220014
- Supplement
- S002
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- CraniSeal Dural Sealant
- Generic name
- Sealant, dural
- Applicant
- Pramand, LLC
- Date received
- 2023-11-21
- Decision date
- 2023-12-20
- Days to decision
- 29 days
- Decision code
- OK30
- Product code
- NQR
- Advisory committee
- Neurology
- Expedited review
- No
- Location
- Bedford, MA
- Statement
- a change to improve the repeatability of a quality control test method for the CraniSeal precursors
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.